Tamar M van Veenendaal1,2, Walter H Backes1,2, Richard AE Edden3,4, Nicholaas AJ Puts3,4, Dominique M IJff2,5, Albert P Aldenkamp2,5, and Jacobus FA Jansen1,2
1Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 2School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands, 3Russel H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, United States, 4F.M. Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States, 5Epilepsy Center Kempenhaeghe, Heeze, Netherlands
Synopsis
Some
authors claim that the 3.7 ppm Glx peak, measured with MEGA-PRESS, constitutes
predominantly glutamate. This claim was tested measuring nine phantoms with
different glutamate, glutamine, and GABA
concentrations using a MEGA-PRESS sequence on a 3T MR scanner. The spectra were
analyzed with Gannet (to measure the Glx peak) and LCModel (as an alternative
approach). The results show that both glutamate and glutamine attribute to the
Glx peak, but that an exclusive estimation of glutamate and glutamine is possible
by using LCModel for analysis.Purpose
The MEGA-PRESS sequence is especially designed for the
detection of γ-aminobutyric acid (GABA), but also enables an estimation of the
so-called ‘Glx’ concentration. This Glx concentration is a combined measure of
glutamate and its precursor glutamine, from which the concentrations are
difficult to disentangle due to overlapping resonance frequencies. However, some
authors claim that this 3.7 ppm Glx peak constitutes predominantly glutamate (see
for instance Ref [1-3]), which is attractive as this enables the measurement of
both major neurotransmitters glutamate and GABA with the same sequence. In this
phantom study, we therefore tested this claim by assessing associations of the
actual concentrations of glutamate, glutamine, and the chemically related GABA on
the resulting ‘Glx’ measurements with MEGA-PRESS sequences. Additionally, the spectra
were also analyzed with LCModel, which estimates the metabolite concentrations
by a linear combination of individual metabolite spectra, rather than by
fitting one peak, which is a commonly applied method to estimate the Glu
concentration.
Methods
Phantoms: Nine 350 mL phantom solutions were made out of a stock solution, including
physiological concentrations of creatine (7.8 mM), myo-Inositol (5.9 mM), N-acetylaspartate
(10.3 mM) and choline (1.7 mM). Glutamate, glutamine and GABA were added to the
solutions in different concentrations, varying from 0-18 mM, 0-9 mM, and 0-3.5
mM for glutamate, glutamine, and GABA, respectively. The pH of these solutions was
set to 7.2 using NaOH.
Measurements:
MRS was performed on the day of phantoms preparation and included a MEGA-PRESS (TE/TR
68/2000 ms, 320 averages, with editing pulses at 1.9 (ON) and 7.46 ppm (OFF)
interleaved in 40 blocks, MOIST water suppression, voxel size 3x3x3 cm3)
on a 3T Philips Achieva TX MR scanner with a 32 channel head coil. Each phantom
was measured twice, while the temperature was controlled to 36.5-38°C.
Analysis:
Gannet (version 2.0) was applied to estimate the ‘Glx peak’ in the MEGA-PRESS difference
spectrum (Figure 1A) using a double Gaussian fit[4]. The MEGA-PRESS difference
spectrum was also analyzed with LCModel (version 6.3-1B, Figure 1B). Concentrations
were considered relative to creatine (Gannet) or N-acetylasparatate (LCModel). The
mean concentrations of the repeated measurements were considered for subsequent
analyses. To assess the relative contributions of the glutamate, glutamine, and
GABA concentrations to the Glx concentration, linear regression analysis was
applied with the measured ‘Glx peak’ as dependent variable, and preset
metabolite concentrations as independent variables. To assess the accuracy, the
Pearson correlation coefficient was calculated between the actual and measured
concentrations of glutamate and glutamine as measured with LCModel. Finally, for
the reproducibility, the mean coefficient of variation (CV) was calculated over
the two subsequent measurements.
Results
The regression analysis showed significant
associations of both glutamate and glutamine with the Glx peak measured with MEGA-PRESS,
with comparable regression coefficients (Table 1, Figure 2). The individual
LCModel estimates showed a high correlation with the prepared glutamate and
glutamine concentrations, with R2>0.96 in all measurements. The CVs
of the glutamine measurements (6.9%) were approximately twice as high as those
of the glutamate (3.2%) or Glx measurements (3.2%).
Discussion
The results show that both glutamate and glutamine
contribute strongly to the Glx peak measured with a MEGA-PRESS sequence. The in vivo glutamate concentration is
roughly twice the glutamine concentration
[5], suggesting that approximately
two-third of the Glx estimate represents glutamate, while the remaining portion
is glutamine. This result contradicts a previous in vivo study, that concluded that the Glx peak in MEGA-PRESS
constitutes mainly glutamate, based on a comparison between the Glx measure
from MEGA-PRESS and glutamate and Glx measures from CT-PRESS
[6].
However, as the glumate and Glx concentration are strongly correlated, the
independent contribution of glutamate to Glx cannot be estimated in vivo.
Estimations by LCModel for glutamate and glutamine
showed high correlations to the actual concentrations and low CVs, as was shown
previously
[7]. A high reproducibility of these glutamate
measurements was also shown in vivo,
albeit worse for glutamine measurements
[8]. In conclusion, measuring
the ‘Glx’ peak does not yield a reliable and independent estimate of exclusively
glutamate , whereas a reliable estimate of this concentration can be obtained
by analyzing the MEGA-PRESS spectra with LCModel.
Acknowledgements
No acknowledgement found.References
[1] C de la
Fuente-Sandoval, F Reyes-Madrigal, X Mao, P León-Ortiz, O Rodríguez-Mayoral, R
Solís-Vivanco, R Favila, A Graff-Guerrero, DC Shungu. Cortico-Striatal
GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for
Psychosis Investigated with Proton Magnetic Resonance Spectroscopy. Int J of
Neuropsychopharmacol. 2015; 105.
[2] M Cleve M, A
Gussew A, JR Reichenbach. In vivo detection of acute pain-induced changes of
GABA+ and Glx in the human brain by using functional 1H MEGA-PRESS MR
spectroscopy. Neuroimage. 2015;105:67-75.
[3] MS Milak, CJ
Proper, ST Mulhern, AL Parter, LS Kegeles, RT Ogden, X Mao, CI Rodriguez, MA
Oquendo, RF Suckow, TB Cooper, JG Keilp, DC Shungu and JJ Mann. A pilot in vivo
proton magnetic resonance spectroscopy study of amino acid neurotransmitter
response to ketamine treatment of major depressive disorder. Molecular
psychiatry (2015).
[4] RAE Edden, NAJ
Puts, AD Harris, PB Barker, CJ Evans. Gannet: A batch-processing tool for the
quantitative analysis of gamma-aminobutyric acid-edited MR spectroscopy
spectra. J Magn Reson Imaging, 2014; 40(6):1445-52
[5] V
Govindaraju, K Young, AA Maudsley. Proton NMR chemical shifts and coupling
constants for brain metabolites. NMR Biomed. 2000; 13:129-153
[6] DC Shungu, X Mao, M Gu, MS Milak, N Weiduschat,
D Mayer, D Spielman, JJ Man. ‘Glx’ Measured by J-editing/MEGA-PRESS is primarily ‘pure’ glutamate… Or
is it? Proc. Intl. Soc. Mag. Reson. Med. 2013; 21: 3985
[7] ME Henry, TL
Lauriat, M Shanahan, PF Renshaw, JE Jensen. Accuracy and stability of measuring
GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: A
phantom study at 4 Tesla. Journal of Magnetic Resonance 2011; 208: 210-218
[8] RL O’Gorman,
L Michels, RA Edden, JB Murdoch, E Martin. In vivo detection of GABA and
glutamate with MEGA-PRESS: Reproducibility and gender effects. J Magn Reson
Imaging 2011; 33:1262-1267